On October 6, 2021, California Governor Gavin Newson signed into law bill SB535. This bill restricts health insurers from requiring prior authorizations to limit advanced cancer patients’ timely access to biomarker testing. This includes patients with metastatic stage II or IV cancer, including when their cancers progress or recur.
The change in law applies to insurance policies, including those under Medi-Cal managed care plans, which have been issued, amended, or renewed as of July 1, 2000.
TELCOR is an industry leader in the laboratory revenue cycle management and point of care testing markets, providing unparalleled health care software products and services, and exceptional customer support. Our proven implementations are performed by clinically experienced, IT knowledgeable resources who understand each customer’s unique environment.